273
Participants
Start Date
May 31, 2013
Primary Completion Date
February 19, 2019
Study Completion Date
February 19, 2019
Beraprost Sodium 314d Modified Release Tablets
Available as 15 μg tablets for oral, 1 or 2 tablets four times daily (QID) administration
Placebo
Placebo tablets, which are identical in size and appearance to those containing BPS-314d-MR
Beth Israel Medical Center, New York
Mount Sinai Medical Center, New York
Columbia University Medical Center, New York
Winthrop University Hospital, Mineola
Albany Medical College, Albany
Pulmonary Health Physicians, PC, Syracuse
Allegheny General Hospital, Pittsburgh
UPMC Presbyterian Hospital, Pittsburgh
Thomas Jefferson University, Philadelphia
University of Maryland, Baltimore
Johns Hopkins University School of Medicine, Baltimore
Sentara Norfolk General Hospital, Norfolk
University of North Carolina, Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Anderson Pharmaceutical Research, Anderson
Gwinnett Biomedical Research, Lawrenceville
Georgia Clinical Research, Austell
Emory University, Atlanta
Pulmonary & Critical Care of Atlanta, Atlanta
University of Florida College of Medicine, Jacksonville
Mayo Clinic, Jacksonville
University of Florida, Gainesville
Florida Hospital, Orlando
Orlando Health Heart Institute, Orlando
South Miami Heart Specialists, South Miami
Cleveland Clinic Florida, Weston
Bay Area Cardiology Associates, P.A., Brandon
Florida Lung, Asthma, and Sleep Institute, Celebration
University of Alabama at Birmingham, Birmingham
Kentuckiana Pulmonary Associates, Louisville
University of Louisville Department of Medicine, Louisville
Ohio State University, Columbus
University of Toledo Medical Center, Toledo
University Hospitals Case Medical Center, Cleveland
University of Cincinnati, Cincinnati
Indiana University - Health Physicians, Carmel
Beaumont Health Systems, Troy
University of Iowa, Iowa City
Chaim Sheba Medical Center, Ramat Gan
Medical College of Wisconsin, Milwaukee
Advocate Health and Hospitals Corporation, Oakbrook Terrace
Northwestern University, Chicago
University of Chicago Medicine, Chicago
John Ochsner Heart & Vascular Institute, New Orleans
UT Southwestern Medical Center, Dallas
Scott & White Memorial Hospital, Temple
Houston Methodist Hospital, Houston
Methodist Healthcare Clinical Trials Office, San Antonio
University of Colorado Denver, Aurora
South Denver Cardiology Associates P.C., Littleton
Aurora Denver Cardiology Associates, Denver
Soroka Medical Center, Beersheba
University of California Los Angeles, Los Angeles
Keck Medical Center of USC, Los Angeles
Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
Cedars-Sinai Medical Center Heart Institute, Beverly Hills
Harbor-UCLA Medical Center, Torrance
University of California - San Diego, La Jolla
Center for Advanced Pulmonary Medicine, Rancho Mirage
Allianz Research Institute Inc., Fountain Valley
Cottage Pulmonary Hypertension Center, Santa Barbara
University of California San Francisco - Fresno, Fresno
University of California - San Francisco, San Francisco
Stanford University, Stanford
Oregon Health and Science University, Portland
University of Washington Medical Center, Seattle
The Lady Davis Carmel Medical Center, Haifa
Rabin Medical Center-Beilinson Campus, Petah Tikva
Kaplan Medical Center, Rehovot
Hadassah University Hospital - Ein Kerem, Jerusalem
Yale School of Medicine, New Haven
Maine Medical Center, Portland
Brigham and Women's Hospital, Boston
Rutgers University Hospital, Newark
Rhode Island Hospital, Providence
Lead Sponsor
Lung Biotechnology PBC
INDUSTRY